← Nutex Health Inc. NUTX
Market Price
$191.83
Market Cap
$1.28B
P/E Ratio
18.30
Revenue (FY 2025)
↑82.4% YoY
$875.26M
3-Yr CAGR: 58.6%
Net Income
↑35.9% YoY
$70.79M
Net Margin: 8.1%
Free Cash Flow
↑1,077.9% YoY
$245.60M
FCF Yield: 19.19%
EPS (Diluted)
↑8.2% YoY
$10.48
Basic: $11.13
Return on Equity
Efficiency
21.5%
ROA: 287.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (NUTX)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | — | — | — | $-7.4M | — | $-0.19 | — | $-0.3M | — | — |
| FY 2017 | $0.0M | — | $-0.0M | $0.6M | +107.8% | — | — | $-0.7M | — | — |
| FY 2018 | $0.1M | +160.0% | $0.0M | $-2.8M | -583.5% | — | — | $-0.8M | $-0.8M | — |
| FY 2019 | $1.4M | +2,168.9% | $0.5M | $-7.1M | -152.9% | — | — | $-4.0M | $-4.1M | -438.8% |
| FY 2020 | $1.6M | +16.1% | $0.7M | $-5.7M | +20.6% | $0.18 | — | $-1.5M | $-1.5M | +64.2% |
| FY 2021 | $18.8M | +1,085.0% | $4.1M | $-13.7M | -141.9% | $0.22 | +22.2% | $-6.7M | $-43.6M | -2,857.8% |
| FY 2022 | $219.3M | +1,066.8% | $13.5M | $-424.8M | -3,007.7% | $-0.67 | -404.5% | $50.6M | $36.0M | +182.5% |
| FY 2023 | $247.6M | +12.9% | $34.8M | $-45.8M | +89.2% | $-0.07 | +89.6% | $1.3M | $-8.2M | -122.9% |
| FY 2024 | $479.9M | +93.8% | $196.3M | $52.1M | +213.8% | $9.69 | +13,942.9% | $23.2M | $20.8M | +353.0% |
| FY 2025 | $875.3M | +82.4% | $444.3M | $70.8M | +35.9% | $10.48 | +8.2% | $248.1M | $245.6M | +1,077.9% |
Valuation
Market Price
$191.83
Market Cap
$1.28B
Enterprise Value
$1.14B
P/E Ratio
18.30
P/B Ratio
4.01
FCF Yield
19.19%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
50.76%
Operating Margin
31.49%
Net Margin
8.09%
Return on Equity (ROE)
21.49%
Return on Assets (ROA)
287.11%
Asset Turnover
35.50x
Revenue 3-Yr CAGR
58.62%
Financial Health & Liquidity
Current Ratio
0.16
Cash Ratio
1.18
Debt / Equity
0.129
Debt / Assets
1.724
Cash & Equivalents
$185.57M
Total Debt
$42.51M
Book Value / Share
$47.88
Cash Flow Efficiency
Operating Cash Flow
$248.12M
Capital Expenditures (CapEx)
$2.53M
Free Cash Flow
$245.60M
OCF / Revenue
28.35%
FCF / Revenue
28.06%
FCF 3-Yr CAGR
89.70%
Per Share Metrics
EPS (Diluted)
$10.48
EPS (Basic)
$11.13
Dividends / Share
N/A
Book Value / Share
$47.88
EPS YoY Growth
8.15%
Balance Sheet (FY 2025)
Total Assets
$24.66M
Total Liabilities
$157.91M
Stockholders' Equity
$329.45M
Current Assets
$24.66M
Current Liabilities
$157.91M